GUTS - Fractyl Health, Inc. Common Stock
Fractyl Health, Inc. Common Stock Logo

GUTS - Fractyl Health, Inc. Common Stock

https://fractyl.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
Bullish
This Broadcom Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Broadcom ( NASDAQ:AVGO ) , Fractyl Health ( NASDAQ:GUTS )
Benzinga • 4 hours, 25 minutes ago • score: 0.16
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Chardan Capital analyst Daniil Gataulin initiated coverage on Ocular Therapeutix, Inc.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company is headquartered in Lexington, Massachusetts.

52W High
$3.50
52W Low
$0.83
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
N/A
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
6163.78
P/S (TTM) (<3 favorable)
3844.55
P/B (<3 favorable)
1.86
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
3.34%
Institutions (25–75% balanced)
53.84%
Shares Outstanding
70,825,000
Float
27,939,100
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
17,000
Gross Profit (TTM)
10,000
EPS (TTM)
-2.10
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-5873.06%
ROE (TTM) (>15% strong)
-3.80%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.57
Momentum
Bearish momentum
Value
-0.0968
Previous
-0.1096
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025